InvestorsHub Logo
Followers 297
Posts 7470
Boards Moderated 0
Alias Born 12/04/2010

Re: None

Tuesday, 10/18/2016 10:23:25 PM

Tuesday, October 18, 2016 10:23:25 PM

Post# of 5918
GWPH I have a hard time imagining the legendary GWPH Big Board MJ play staying quiet going into November, could be wrong, but it would be hard to imagine

Cowen P.T. 135 Outperform

Piper Jeffray Overweight P.T. 147

Cantor Fitzgerald Buy Rating P.T. 181


http://www.americanbankingnews.com/2016/09/27/cowen-and-company-reiterates-outperform-rating-for-gw-pharmaceuticals-plc-gwph.html

Goldman Sachs P.T. 189 M&A Potential Value 349

https://www.newcannabisventures.com/goldman-sachs-suggests-potential-gw-pharma-acquisition-price-of-349/

Seems a little cheap right now imo

All posts are my own opinions. All investors should do their own due diligence in making decisions.



Trade from a position of strength